Institutional & Family Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	$2.46K	Hold	398	–	–	﹤0.01%	558
2024 Q1	$2.02K	Hold	398	–	–	﹤0.01%	579
2023 Q4	$2.38K	Hold	398	–	–	﹤0.01%	546
2023 Q3	$2.82K	Hold	398	–	–	﹤0.01%	530
2023 Q2	$2.8K	Hold	398	–	–	﹤0.01%	543
2023 Q1	$3.32K	Hold	398	–	–	﹤0.01%	519
2022 Q4	$4.57K	Hold	398	–	–	﹤0.01%	481
2022 Q3	$5K	Sell	398 -2	-0.5%	-$25	﹤0.01%	467
2022 Q2	$4K	Hold	400	–	–	﹤0.01%	512
2022 Q1	$7K	Hold	400	–	–	﹤0.01%	478
2021 Q4	$6K	Hold	400	–	–	﹤0.01%	517
2021 Q3	$6K	Hold	400	–	–	﹤0.01%	622
2021 Q2	$6K	Hold	400	–	–	﹤0.01%	667
2021 Q1	$4K	Hold	400	–	–	﹤0.01%	707
2020 Q4	$3K	Hold	400	–	–	﹤0.01%	689
2020 Q3	$1K	Hold	400	–	–	﹤0.01%	763
2020 Q2	$2K	Hold	400	–	–	﹤0.01%	672
2020 Q1	$1K	Hold	400	–	–	﹤0.01%	704
2019 Q4	$1K	Hold	400	–	–	﹤0.01%	790
2019 Q3	$1K	Hold	400	–	–	﹤0.01%	765
2019 Q2	$2K	Hold	400	–	–	﹤0.01%	688
2019 Q1	$3K	Hold	400	–	–	﹤0.01%	648
2018 Q4	$3K	Hold	400	–	–	﹤0.01%	628
2018 Q3	$3K	Hold	400	–	–	﹤0.01%	660
2018 Q2	$2K	Hold	400	–	–	﹤0.01%	700
2018 Q1	$2K	Buy	+400	New	+$2K	﹤0.01%	697